United Therapeutics Corp. (UTHR) Tops Q1 EPS Views
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $536.59 --0%
EPS Growth %: +12.6%
Financial Fact:
Cost of product sales: 23.6M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +12.6%
Financial Fact:
Cost of product sales: 23.6M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
United Therapeutics Corp. (Nasdaq: UTHR) reported Q1 non-GAAP EPS of $1.29, $0.65 better than the analyst estimate of $0.64. Revenue for the quarter came in at $165.6 million versus the consensus estimate of $178.02 million.
United Therapeutics reported non-GAAP EPS of $1.13 in Q210.
United Therapeutics reported non-GAAP EPS of $1.13 in Q210.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Safe Bulkers (SB) Tops Q1 EPS by 7c
- Sonoma Pharmaceuticals (SNOA) Misses Q4 EPS by 33c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
